8959.92 36.91 (0.41%)
You are here :
MONEYCONTROL >
MARKETS >
SHARE PRICE >
PHARMACEUTICALS >
COMPANY INFO - RANBAXY LABORATORIES
Ranbaxy Laboratories
SET SMS ALERTAdd to Watchist
Have you invested in these stocks? You can track them better in your Portfolio
|
|
LIVE
BSE
May 22, 17:00
431.10
-5.25 (-1.20%)
VOLUME 138,449
AVERAGE VOLUME
| 5-Day | 151,239 |
| 10-Day | 185,107 |
| 30-Day | 114,873 |
VOLUME SHOCKER
| 5-Day | 151,239 |
| 10-Day | 185,107 |
| 30-Day | 114,873 |
Prev. Close
436.35
Open Price
436.00
Bid PRICE (QTY.)
0.00 (0)
Offer PRICE (Qty.)
431.10 (31)
Today’s Low/High
427.70
436.00
52 Wk Low/High
370.50
578.30
LIVE
NSE
May 22, 17:00
431.05
-5.30 (-1.21%)
VOLUME 1,110,661
AVERAGE VOLUME
| 5-Day | 1,321,923 |
| 10-Day | 1,324,184 |
| 30-Day | 860,473 |
VOLUME SHOCKER
| 5-Day | 1,321,923 |
| 10-Day | 1,324,184 |
| 30-Day | 860,473 |
Prev. Close
436.35
Open Price
435.00
Bid PRICE (QTY.)
0.00 (0)
Offer PRICE (Qty.)
431.05 (3412)
Today’s Low/High
427.60
435.00
52 Wk Low/High
370.80
578.40
Action in Ranbaxy Laboratories
MARKET CAP (Rs Cr)
18,239.88
*P/E
-
*BOOK VALUE (Rs)
45.40
DIV (%)
0.00%
Market Lot
1
INDUSTRY P/E
27.76
*EPS (TTM)
-
*P/C
-
*PRICE/BOOK
9.50
DIV YIELD.(%)
-%
FACE VALUE (Rs)
5.00
DELIVERABLES (%)
* Based on standalone numbers
Track Ranbaxy Labs on the go with moneycontrol app
COLLAPSE ALL
Would you bet on Ranbaxy Labs today?
Test your strategy with virtual money on Moneybhai
F&O Quote
Historic Prices & Simple Moving Averages
Simple Moving Averages
| Days | BSE | NSE |
| 30 | 449.92 | 450.18 |
| 50 | 444.23 | 444.44 |
| 150 | 472.11 | 472.29 |
| 200 | 487.26 | 487.45 |
Click here to view the Open, High, Low, Close, Volume and Spread data for Ranbaxy Labs
News/Videos & Announcements
News
May 22, 2013
Daiichi may sue ex-Ranbaxy promoters for false info
May 20, 2013
Pharma losing health: 4 reasons that led to weakness
May 17, 2013
Drugmakers fall on government price control policy
Announcements
May 22, 2013
Ranbaxy Labs - Ranbaxy Highlights Improved Business and Quality Assurance Standards - Dedicated to Providing Safe and Efficacious Medicines Globally
Videos
May 22, 2013
May 21, 2013
May 21, 2013
Stock Advice & Research Reports
Stock Advice
Research Reports
News Across the Web
Financials
Income Statement
(In Rs Cr)
| (Mar '13) Quarterly |
(Dec '12) Yearly |
|
| Net Sales | 1381.64 | 6303.54 |
| Other Income | 52.33 | 239.60 |
| PBDIT | 84.21 | 700.08 |
| Net Profit | 70.15 | -162.34 |
Balance Sheet
(Dec '12)
(In Rs Cr)
(In Rs Cr)
| Total Share Capital | 211.46 |
| Net Worth | 1922.08 |
| Total Debt | 4763.61 |
| Net Block | 1993.53 |
| Investments | 3131.17 |
| Net Current Assets | 1401.38 |
| Total Assets | 6685.68 |
Peers
Peer Comparison
| Company Name | Last Price | % Change |
52 wk High |
52 wk Low |
Market Cap |
| Sun Pharma | 1001.90 | 2.90 | 1013.10 | 569.00 | 103,754.96 |
| Dr Reddys Labs | 2056.55 | 1.84 | 2150.90 | 1555.00 | 34,927.72 |
| Lupin | 768.50 | -0.05 | 810.80 | 519.00 | 34,400.91 |
| Cipla | 415.25 | -0.44 | 435.00 | 305.00 | 33,341.31 |
| GlaxoSmithKline | 2277.45 | 0.07 | 2522.00 | 2005.00 | 19,290.69 |
| More » | |||||
Share Holding Pattern & Mutual Funds Holding
Share Holding Pattern in (%)
| Mar' 13 | Dec' 12 | Sep' 12 | Jun' 12 | |
| Promoter | 63.52 | 63.54 | 63.64 | 63.66 |
| FII | 10.55 | 10.65 | 10.57 | 9.66 |
| DII | 10.03 | 10.39 | 10.63 | 11.08 |
| Others | 15.90 | 15.42 | 15.16 | 15.60 |
| Total | 100.00 | 100.00 | 100.00 | 100.00 |
Mutual Funds Holding
| Scheme | No. of Shares |
| Reliance Growth Fund - Retail Plan (G) | 3,074,941 |
| Reliance Equity Opportunities Fund - Retail Plan (G) | 2,251,826 |
| Reliance Pharma Fund (G) | 1,500,600 |
| Reliance Top 200 Fund - Retail Plan (G) | 581,121 |
Company Information
REGISTERED OFFICE
Address
A-41, Industrial Area, Phase-VIII-A,,Sahibzada Ajit Singh Nagar
City
Mohali
State
Punjab
Pin Code
160071
Tel. No.
0172-6678666
Fax No.
0172-5013376
Email:
Internet
REGISTRARS
Name
Alankit Assignment Ltd.
Address
2E/8, Blazeflash House, R T A Division, 1st Floor Jhandewalan Extension,
City
New Delhi - 110055
State
Delhi
Tel. No.
011-51540060, 51540061, 51540062, 51540063
Fax No.
011-51540064
Email:
MANAGEMENT
Name
Designation
Tsutomu Une
Chairman
Arun Sawhney
Managing Director & CEO
Akihiro Watanabe
Director
Anthony H Wild
Director
Kazunori Hirokawa
Additional Director
Message Board & Community
Quick Links for Ranbaxy Laboratories
Related Searches
Ranbaxy Laboratories Stock Price, Ranbaxy Labs Stock Quote, Ranbaxy Labs Results , Ranbaxy Labs News ..
More »
Follow moneycontrol.com
Explore Moneycontrol
Mutual Funds
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
News |
Markets |
IPO |
Technicals |
Mutual Fund |
Commodities |
Best Portfolio Manager |
Bse Sensex |
Bombay Stock Exchange |
Share Market Live |
Recession 2011 |
Commodities Price |
Silver Price/Rate in India |
Gold Price/Rate in India |
Crude Oil |
USD to INR |
National Stock Exchange |
Bank Fixed Deposits |
Company Fixed Deposits |
Small Savings Schemes |
Property rates in India |
Rss Feeds | Budget:2008, 2009, 2010, 2011, 2012 |
Intuit Money Manager |
RBI Credit Policy | BSE A Group Companies | BSE B Group Stocks | Union Budget
| Financial Glossary
|
Message Board |
Moneybhai |
India's Premiere Technology Guide |
History India | Davos
| ING Vysya Bank Limited | National Institute of Design | Reserve Bank of India | Sreesanth | Indian Premier League | Coal | Chandigarh | Mumbai | Ranbaxy Laboratories Limited (ADR) | Puravankara Projects Limited
Site Map | About Us | Contact Us | Advertise | Bookmark | Disclaimer | Privacy Statement | Terms of Use | Careers
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.